BlackRock Fund Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.31M Buy
409,775
+96,302
+31% +$1.48M ﹤0.01% 2905
2016
Q3
$5.12M Buy
313,473
+23,180
+8% +$419K ﹤0.01% 2832
2016
Q2
$3.6M Buy
290,293
+129,164
+80% +$1.61M ﹤0.01% 2990
2016
Q1
$1.73M Sell
161,129
-8,547
-5% -$77.7K ﹤0.01% 3111
2015
Q4
$2.49M Buy
+169,676
New +$2.08M ﹤0.01% 3096

Other funds holding MYOK

BlackRock Fund Advisors's MYOK Position: Q4 2016 in Review

BlackRock Fund Advisors increased its MyoKardia, Inc. Common Stock (MYOK) stake by 31% in Q4 2016, buying an estimated $1.48M and bringing the position to 409,775 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2905.

BlackRock Fund Advisors first reported a position in MYOK in Q4 2015 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold MYOK as of Q4 2016.

  • BlackRock Fund Advisors held 409,775 shares of MyoKardia, Inc. Common Stock worth $5.31M as of Q4 2016.
  • BlackRock Fund Advisors bought 96,302 MyoKardia, Inc. Common Stock shares in Q4 2016, an estimated $1.48M.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2905 holding.
  • BlackRock Fund Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.